Morning roundup: AAFP leadership, Roche MS pill data, and firefighter cardiac screening
This medical news roundup covers the AAFP's selection of Kisha Davis, M.D., as its new president. It also reports that a Roche oral multiple sclerosis treatment slowed chronic lesion growth and that standard stress tests may fail to detect heart risk in firefighters.
The roundup covers three healthcare developments. The AAFP has selected Kisha Davis, M.D., as its new president. Roche reported that an oral multiple sclerosis treatment slowed chronic lesion growth. Separately, standard stress tests may fail to identify heart risk among firefighters.
These items touch on professional medical leadership, neurological treatment research, and occupational cardiac screening. The supplied material offers no further specifics about the selection process, trial design, or screening protocol.
The AAFP leadership change may influence how the organization represents its members and discusses relevant clinical issues, potentially affecting clinicians and patients connected to it. The Roche MS finding, if confirmed, could matter to people with multiple sclerosis and their care teams. Firefighter screening results may prompt occupational health discussions about protecting first responders, though the supplied summary does not establish policy changes.